MRI Neurofeedback and Brain Circuits Related to Motivation in Healthy Participants

Официальное название

Bridging Scales to Understand Endogenous Neuromodulation and Its Regulation

Обзор

The purpose of this research study is to understand how healthy individuals self-regulate motivation by observing brain activity using magnetic resonance imaging (MRI).

Подробное описание

Neuromodulatory nuclei detect and transform brain network activity into simpler signals, then send neurotransmitters back out to large-scale brain networks to change their function. Such nuclei are centrally implicated in mental disorders and adaptive resilience, and their regulation remains an untapped resource for interventions. The purpose of this study is to understand how neuromodulatory nuclei detect and in turn influence distributed patterns of brain activity to impact behavior. In order to understand their regulation and effects on brain function, the investigative team has developed novel neuroimaging, behavioral, and analytic methods. These methods include: training participants to endogenously self-regulate dopaminergic midbrain and then relating midbrain activation to memory-conducive states, effort exertion, and decision making.

If the aims of this project are achieved, the investigators will have methods for regulating midbrain noninvasively, an improved understanding of its impact on learning and motivated behavior, and reliable cognitive strategies for a wide array of interventions across educational and clinical applications.

Вмешательства

• Поведенческое Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback
  fMRI neurofeedback training of sustained midbrain/VTA activation via motivational imagery.

Первичные конечные точки

• Percent signal change in VTA BOLD activation [Срок оценки: During the MRI scan, approximately 2 hours]

Вторичные конечные точки (2)

• Change in effort-based decision making, as measured by the Effort Expenditure for Reward Task (EEfRT) [Срок оценки: During the MRI scan, approximately 2 hours]
• Change in motivated memory, as measured by the Monetary Incentive Encoding task (MIE) [Срок оценки: During the MRI scan, approximately 2 hours]

Критерии участия

Критерии включения

• Age between 18 and 45 years
• Right-handed
• In good general health

Критерии исключения

• Current or diagnosis within past six months of an DSM-V Axis I or Axis II disorder (self-reported)
• CES-D score of 20 or higher (indicating significant current depression symptoms)
• Current or past six month use of prescription medications indicated for psychiatric conditions (e.g.,depression, anxiety)
• Current serious medical illness (self-reported)
• Head injury resulting in loss of consciousness
• For participants age > 59 years, a total scaled score < 8 on the Dementia Rating Scale-2.
• A clinically-defined neurological disorder including, but not limited to:
• Any condition likely to be associated with increased intracranial pressure
• Space occupying brain lesion
• History of stroke
• Transient ischemic attack within two years
• Cerebral aneurysm
• Dementia
• Mini Mental Status Exam (MMSE) score of <24
• Parkinson's disease
• Huntington's disease
• Multiple sclerosis
• Presence of cochlear implants or other implanted electronic devices or non-removable metal (e.g., non-removable piercing, IUD)
• History of an eye injury involving metal. Participants who worked with metal may be allowed to participate on a case-by-case basis with prior written approval from BIAC.
• Claustrophobia or unwillingness to tolerate the confinement associated with being in the MRI scanner.
• Weight of more than 250 pounds

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Открытое

Основная цель

Фундаментальное исследование

Центры проведения

США · 1 центр

• Center for Cognitive Neuroscience — Durham

Идентификаторы

NCT: NCT05929898 · Pro00112672 · 1R01MH131667-01

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗